Does this Tesamorelin dosage calculator choose a dose?

No. The target amount must come from the current prescription and formulation-specific instructions. The page calculates concentration, mL, and U-100 markings only.

Can I use EGRIFTA WR values for EGRIFTA SV?

No. DailyMed states that the recommendations for the 11.6 mg-vial EGRIFTA WR formulation apply only to that formulation and points to separate information for the 2 mg-vial formulation.

How does the calculator convert tesamorelin mg to units?

It divides target mg by the verified concentration in mg/mL to obtain mL, then multiplies mL by 100 to express the same volume on a U-100 scale.

Does a U-100 unit measure tesamorelin mass?

No. U-100 markings measure liquid volume. The tesamorelin mass represented by that volume depends on the formulation-specific concentration.

Can this calculator replace the EGRIFTA instructions?

No. It does not cover product preparation, administration, storage, indication, contraindications, monitoring, or other prescribing information.

Prescription GHRF analog · unit conversion

Tesamorelin Dosage Calculator

Use this Tesamorelin dosage calculator to check mass-to-volume arithmetic only when the exact formulation and label values are known. It does not choose a dose, replace EGRIFTA instructions, or generalize one presentation to another.

Peptide-specific contextTransparent conversion examplesNo recommended dose

Calculate your Tesamorelin conversion

Replace the example values with the total vial amount, final liquid volume, and target mass from one current label or qualified instruction. The calculator does not choose a dose.

Total amount in vial

Final liquid volume

Target mass

Inputs stay in this browser. No account or saved calculation is required.

Live calculation

Concentration

5 mg/mL

Liquid volume

0.05 mL

U-100 marking

5 units

Mathematical doses per vial

0.25 mg ÷ 5 mg/mL = 0.05 mL × 100 = 5 units

Open the full Peptide Calculator

Illustrative arithmetic · not dosing guidance

Tesamorelin Example Conversion Table

Every row is arithmetic based on 10 mg in 2 mL, producing a concentration of 5 mg/mL. This is not a mixing instruction. The target values are mathematical examples. They are not common, prescribed, or recommended doses.

Example target	Volume at 2.5 mg/mL	U-100 marking
0.25 mg	0.05 mL	5 units
0.5 mg	0.1 mL	10 units
1 mg	0.2 mL	20 units

These rows use an invented concentration to demonstrate arithmetic. They are not EGRIFTA WR or EGRIFTA SV preparation directions, labeled doses, or interchangeable product instructions.

Open Peptide Calculator

Read the numbers in order

Formulation checks for tesamorelin calculations

Tesamorelin is a clear example of why ingredient names alone are not enough. The formulation name, vial strength, supplied diluent, final volume, and instructions must stay together.

Identify WR, SV, or another presentation first

EGRIFTA WR and EGRIFTA SV are formulation names, not decorative labels. Their vial strengths and instructions differ. A Tesamorelin dosage calculator should never move a diluent volume or concentration from one formulation to the other. Read the complete product name and use the prescribing information written for that exact presentation.

A product described only as tesamorelin may not provide enough information to calculate. If the label omits the final volume, component strength, or required preparation instructions, do not substitute values from an approved product. The calculator cannot establish pharmaceutical equivalence from a shared active-ingredient name.

Follow the concentration chain without shortcuts

The formula starts with total mass divided by final liquid volume. A deliberately hypothetical 10 mg in 2 mL equals 5 mg/mL. A mathematical target of 0.5 mg would then equal 0.1 mL and 10 units on a U-100 scale. These values are chosen to make the decimal relationship easy to inspect, not to represent an EGRIFTA formulation or labeled dose.

If official instructions already provide a prepared concentration, compare it with the concentration calculated from the entered mass and volume. A disagreement usually points to a wrong formulation, wrong final volume, or unit error. Resolve the source values rather than changing the target to force agreement.

Keep clinical instructions attached to the product label

A volume converter does not interpret indication, frequency, storage, compatibility, missed doses, or adverse effects. It also cannot determine whether a vial should be used after a preparation error. Those questions belong to the current prescribing information and a licensed prescriber or pharmacist.

Record the formulation name beside any saved calculation. Include total vial mass, final volume, target unit, concentration, calculated mL, and U-100 marking. Without the formulation name, a clean set of numbers can later be mistaken for a different tesamorelin presentation, which defeats the purpose of a product-specific page.

Three-step calculation

How to use this Tesamorelin dosage calculator

This page explains the calculation. The shared Peptide Calculator applies values you already have and never chooses a vial amount, liquid volume, target mass, or schedule.

1. Read the current label

Enter the total Tesamorelin amount printed on the vial and the total liquid volume for that same vial. Do not combine values from two products.

2. Open the shared calculator

Use the CTA above to preselect Tesamorelin, then replace every illustrative value with the vial, liquid, and target values from your qualified source.

3. Verify every unit

Read concentration first, then mL, then the U-100 marking. Repeat the decimal and unit conversion independently before relying on the result.

Product-specific context

Tesamorelin formulation-specific instructions

Tesamorelin is available in named prescription formulations with different vial strengths and product-specific directions. DailyMed warns that recommendations for the EGRIFTA WR 11.6 mg-vial formulation do not apply to the 2 mg-vial formulation. The shared ingredient name does not make their preparation steps interchangeable.

This page does not reproduce the prescribing instructions for either product. It accepts values only after the user has identified the exact presentation and obtained the applicable mass, liquid volume, and target amount from authoritative instructions.

The calculator then applies ordinary concentration math. It cannot decide whether the labeled indication applies, check contraindications, choose a target, or confirm that a compounded or unlabeled vial matches an approved EGRIFTA product.

Transparent arithmetic

Tesamorelin Calculation Formula

The name does not change the equations. Concentration links mass to volume; the U-100 conversion is applied last.

FORMULA 1

Concentration

vial mg ÷ liquid mL = mg/mL

FORMULA 2

Dose volume

target mg ÷ mg/mL = mL

FORMULA 3

U-100 marking

dose mL × 100 = units

If the target is entered in mcg, divide by 1,000 before using the dose-volume formula. The linked calculator does this conversion internally while keeping both mass units visible in the result.

Before accepting a result

Tesamorelin Label and Input Checks

Read the complete formulation name

Do not transfer mass, diluent, final volume, or preparation directions between EGRIFTA WR, EGRIFTA SV, and another product.

Use the applicable prescribing information

The product label, not a generic chart, determines which input values and preparation steps belong together.

Do not use examples as instructions

The values on this page illustrate equations and are not approved-product specifications, recommended doses, or mixing directions.

Common questions